Wednesday, 14 October 2026European Markets

KINEPOLIS GROUP And BOLLORE Have A High Dividend Yield And Return On Equity In The Entertainment Industry.

Loading stream...

(vianews) - kinepolis group (kin.br) is among this list of stock assets with the highest dividend rate and return on equity on the entertainment industry.

financial asset price forward dividend yield return on equity
kinepolis group (kin.br) €40.30 1.24% 31.91%
bollore (bol.pa) €6.19 1.12% 1.13%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. kinepolis group (kin.br)

1.24% forward dividend yield and 31.91% return on equity

kinepolis group nv operates cinema complexes in belgium, the netherlands, france, spain, luxembourg, switzerland, poland, canada, and the united states. the company sells cinema tickets, as well as events and vouchers to companies and publicity campaigns in the cinema; and beverages and snacks in the cinemas, as well as offers the self-service shop and other in-theatre sales concepts. it is also involved in international and domestic movie distribution, event organization, screen advertising, and property ownership activities; and the provision of technological services to third parties. the company has a portfolio of 110 cinema complexes, including 51 own complexes comprising 1,124 screens and approximately 200,000 seats. kinepolis group nv was incorporated in 1976 and is based in brussels, belgium.

earnings per share

as for profitability, kinepolis group has a trailing twelve months eps of €2.03.

pe ratio

kinepolis group has a trailing twelve months price to earnings ratio of 19.85. meaning, the purchaser of the share is investing €19.85 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.91%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, kinepolis group's stock is considered to be overbought (>=80).

more news about kinepolis group.

2. bollore (bol.pa)

1.12% forward dividend yield and 1.13% return on equity

bolloré se engages in the transportation and logistics, communications, and industry businesses in france, rest of europe, the americas, asia, oceania, and africa. it operates through bolloré logistics, bolloré energy, communications, and industry segments. the company offers freight forwarding, railroad, and port services; and distributes oil products. it also provides advertising, and communication consulting services; owns and publishes cnews, a french daily newspaper; provides ticketing and venue services; acts as a pay-tv operator; and operates mac-mahon cinema theaters. in addition, it develops batteries based on lithium metal polymer technology for use in electric buses and energy storage solutions, as well as in stationary applications; and polypropylene films for capacitors and electrical components. further, the company integrates identification, tracking, and mobility solutions for retail, transport, and logistics; provides equipment for pedestrian and vehicle access control; and electric shuttles solutions. the company was founded in 1822 and is based in puteaux, france. bolloré se is a subsidiary of financière de l'odet se.

earnings per share

as for profitability, bollore has a trailing twelve months eps of €0.04.

pe ratio

bollore has a trailing twelve months price to earnings ratio of 154.75. meaning, the purchaser of the share is investing €154.75 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.13%.

volume

today's last reported volume for bollore is 761910 which is 11.44% below its average volume of 860426.

sales growth

bollore's sales growth for the current quarter is 57.7%.

yearly top and bottom value

bollore's stock is valued at €6.19 at 12:40 est, below its 52-week high of €6.43 and way higher than its 52-week low of €4.93.

more news about bollore.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com